gsk

Welcome to the 'gsk' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'gsk'.

Latest blogosphere posts tagged “gsk”

• 8 HealthCare Stocks With 3%+ Dividends

  
  SeekingAlpha.com: Home Page — Authority: 640
  Hao Jin submits: In 3 of the past 4 market rebounds since 1982, equity gains slowed to a single-digit pace in the second year, after the initial rally. Now dividend stocks have extra appeal because they offer a tempting alternative to CDs, which pay virtually no interest at all, and long-term bonds, which pay a ...
  22 hours ago

• CENSORED POLISH HEALTH MINISTER SHOWS WISDOM OVER H1N1 SCANDAL

  
  Health and Wellness — Authority: 150
  Censored YouTube cut the first upload down to 2 minutes ! Rt Hon Andy Burnham MP and Sir Liam Donaldson are thinking of profit before the health of the UK’s population. Why is it that Mrs Ewa Kopacz the Polish Health Minister can see what is going on? Why can’t they see what is happening? History will show in the ...
  1 day ago

• GSK Consumer

  
  Dead Presidents! - India Equity Research — Authority: 455
  GSK Consumer
  2 days ago

• (HGSI) Human Genome Sciences Begins Trial

  
  Stock Blog Hub — Authority: 164
  Recently, Human Genome Sciences, Inc . ( HGSI) and Aegera Therapeutics announced the initiation of dosing in a phase I clinical trial to evaluate the safety and tolerability of its lead inhibitor-of-apoptosis protein (IAP), HGS1029, as monotherapy in patients with advanced lymphoid tumors. An additional phase I ...
  4 days ago

• Canada To Stop Using AH1N1 Vaccine

  
  Daily Contributor — Authority: 539
  Canada advised its doctors to stop using a batch of AH1N1 vaccines after reports of severe side effects in some patients. About 172,000 doses of Arepanrix made by GlaxoSmithKline (GSK) were recalled after six Canadians experienced anaphylaxis, which causes breathing problems, low blood pressure and swelling of ...
  4 days ago

• Cel-Scis History of Disappearing Drugs: BioBuzz

  
  TheStreet.com — Authority: 572
  Will the companys flu drug last longer than its other fly-by-night projects?
  5 days ago

• BioCryst Bull Blames Conspiracy for Stocks Fall: BioBuzz

  
  TheStreet.com — Authority: 572
  Hedge funds, Wall Street, SEC and FDA out to hurt maker of flu drug, newsletter writer claims.
  5 days ago

• ZION, VRX, GSK, BW, PEET, DDRX, GMCR Popular Stocks

  
  Ub News — Authority: 496
  U.S. stocks rose Monday, as the Dow Jones Industrial Average gained 125 points to 10443, the S&P 500 climbed 14 points to 1105 and the Nasdaq Composite Index jumped 27 points to 2173.Zions Bancorp Inc. (NASDAQ:ZION, $14.30, +$1.75, +13.94%) announced plans to swap about $140 million of preferred shares for up to 7 ...
  6 days ago

• Healthcare Stocks: Safe and Speculative

  
  TheStreet.com — Authority: 572
  NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio.
  6 days ago

• GSK Regulatory Update: Avodart

  
  Pharmainfo.net — Authority: 171
  GSK announced today that in order to provide an update to the application, the company is withdrawing its US sNDA for Avodart® (dutasteride) for prostate cancer risk reduction among men at increased risk of developing the disease. GSK expects to resubmit the file shortly. This action is not the result of new ...
  6 days ago

• The Dean’s Swine Flu Profit Storm is on Its Way

  
  CollegeStock - The Dean of College Stocks — Authority: 139
  The Dean believes Swine Flu Frenzy will carry well into flu season and, with companies like Novartis (NYSE: NVS), GlaxoSmithKline (NYSE: GSK), Sanofi-Pasteur (NYSE: SNY) and BioCryst Pharmaceuticals (NASDAQ: BCRX) contracted to produce millions of vaccine doses, there’s billions in profits to be made.The Dean thinks ...
  6 days ago

• Pandemic 2009 Influenza Update: Pandemrix™ data in children and adolescents from 3 to 17 years of age

  
  Pharmainfo.net — Authority: 171
  GlaxoSmithKline (GSK) today announced that over 40 million doses of its adjuvanted pandemic H1N1 vaccine have been distributed to countries globally for use in government-initiated vaccination programmes. Advertisement: read more
  6 days ago

• China Biotech Week in Review: CROs Consolidating

  
  SeekingAlpha.com: Home Page — Authority: 640
  ChinaBio Today submits: In late October, when PPD, Inc. (NSDQ: PPDI ) acquired fellow CRO Excel PharmaStudies, we suggested more CRO consolidation might follow. However, it was both a surprise – and not a surprise – when the news broke that PPD would follow up its Excel transaction with another major CRO ...
  1 week ago

• GlaxoSmithKline Takes Three-Pronged Approach in China to Fight H1N1 Flu

  
  SeekingAlpha.com: Home Page — Authority: 640
  ChinaBio Today submits: GlaxoSmithKline (NYSE: GSK ) will begin manufacturing its treatment for flu, Relenza, in China to supply China’s domestic market. GSK received approval of the drug in September from the SFDA. Relenza, like Tamiflu from Roche ( RHHBY.PK ), aims at reducing both the severity and the ...
  1 week ago

• Adverse reactions to the Swine Flu vaccine soar

  
  Holy Hormones, Honey! — Authority: 141
  American Chronicle November 21, 2009 by Christina England Glaxo Smith Kline have recalled a batch of Swine Flu vaccines containing around 170,000 vaccines in Canada, due to a larger than expected number of adverse reactions. GSK say that they expect to have reports of a severe adverse reaction in a approx 1 in ...
  1 week ago

• Batch of H1N1 vaccine pulled after bad reactions

  
  Holy Hormones, Honey! — Authority: 141
  CTV News Manitoba, Canada November 20, 2009 More than 100,000 doses of the H1N1 vaccine are being withdrawn across the country, after Manitoba health officials announced Thursday they’d noticed a higher-than-usual number of allergic reactions from one batch. Vaccine manufacturer GlaxoSmithKline has asked ...
  1 week ago

• (BIIB) Biogen’s Rituxan Label Expansion Delayed

  
  Stock Blog Hub — Authority: 164
  Biogen Idec ( BIIB ) and Genentech, Inc., a wholly-owned member of the Roche Group (RHHBY.PK), announced that they have received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) for Rituxan. The companies were seeking approval for the use of Rituxan (rituximab) plus fludarabine and ...
  1 week ago

• Fast Money Recap: Playing Defense

  
  TheStreet.com — Authority: 572
  The trading panel discussed moves for a market that is shifting to the downside.
  1 week ago

• (PFE) Pfizer Earns Panel’s Backing for Prevnar 13

  
  Stock Blog Hub — Authority: 164
  Pfizer ( PFE ) announced that the US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products advisory committee voted in favor (10 to 1) of data presented to support the safety and effectiveness of Prevnar 13, its 13-valent pneumococcal conjugate candidate vaccine. The favorable recommendation ...
  1 week ago

• Millions of healthy children to be given swine flu jab

  
  Daily Telegraph | Telegraph.co.uk — Authority: 969
  Children under five three times most likely to be admitted to hospital and in some areas paediatric beds are filling up.
  1 week ago

Comments about gsk